Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia
N Engl J Med
.
2016 Nov 24;375(21):2100-2101.
doi: 10.1056/NEJMc1612040.
Authors
Hagop M Kantarjian
1
,
Erik Vandendries
2
,
Anjali S Advani
3
Affiliations
1
M.D. Anderson Cancer Center, Houston, TX
[email protected]
2
Pfizer, Cambridge, MA
3
Cleveland Clinic, Cleveland, OH
PMID:
27959720
DOI:
10.1056/NEJMc1612040
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized / therapeutic use*
Humans
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized